About us
At PackGene, we are committed to breaking barriers in gene therapy by providing comprehensive and cost-effective AAV, lentivirus, mRNA and plasmid solutions.
Learn More
-
1,000 +
Clients globally
From biopharmaceutical companies and research institutions -
50,000 +
Projects delivered
From research to GMP production -
120,000 sqf
GMP facility
Viral Vector production
Discovery and Preclinical Service
Empowering scientific breakthroughs that transform lives
- AAV Service
- Lentivirus Service
- mRNA & LNP Service
- Vector Construction
- Plasmid preparation
- Off-the-shelf products
Learn More
GMP Manufacturing Services
One-stop CDMO Services for GMP Manufacturing
- Process Development
- Plasmid GMP Manufacturing
- Viral Vector GMP Manufacturing
- AAV Analytical QC Services
- GMP mRNA & LNP
Learn More
Technology Platforms
π-Alpha 293 AAV High-yield Production Platform
π-Omega High-yield Plasmid Production Platform
π-Icosa Capsid Engineering Platform
Explore
What Customers are Saying About us
Leading technology and global reputation
News and Industry Updates
NewsEventsCitation
-
Ing
AACR Annual Meeting 2025, Chicago, April 25-30
Apr 15 2025 -
Past
PackGene at the Cell & Gene Meeting on the Med 2025
Apr 15 2025 -
Past
Advanced Therapies London (ExCel, London, Mar 18-19, 2025)
Mar 18 2025 -
Past
Rare Disease Day (Feb, 28, 2025) – Breaking Barriers in Rare Disease Gene Therapy
Feb 28 2025 -
Past
PMWC (Silicon Valley, CA, Feb 5-7, 2025)
Feb 05 2025 -
Past
Advanced Therapies Week (Dallas, TX, Jan 20-23, 2025)
Jan 20 2025
